Transient insulin autoantibody expression independent of development of diabetes: Comparison of NOD and NOR strains

被引:31
作者
Abiru, N [1 ]
Yu, LP [1 ]
Miao, DM [1 ]
Maniatis, AK [1 ]
Liu, EW [1 ]
Moriyama, H [1 ]
Eisenbarth, GS [1 ]
机构
[1] Univ Colorado, Hlth Sci Ctr, Barbara Davis Ctr Childhood Diabet, Denver, CO 80262 USA
关键词
insulin autoantibody; NOD mouse; NOR mouse; diabetes; insulitis;
D O I
10.1006/jaut.2001.0530
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 [免疫学];
摘要
NOD mice spontaneously develop anti-insulin autoantibodies associated with the subsequent development of diabetes. NOD mice that express insulin autoantibodies at 8 weeks of age have a diabetes risk exceeding 90%, while mice that do not express autoantibodies by 16 weeks have a risk of less than 20%. NOD female mice expressed insulin autoantibodies more often than male mice (13/15(+) vs. 6/15(+)). Autoantibodies characteristically developed between 8 and 20 weeks and then for most mice became negative at diabetes onset in NOD mice. In the diabetes-free strain NOR mice, spontaneous expression of insulin autoantibodies was observed in less mice (female 8/15(+), male 3/10(+)) compared to NOD mice. The expression of autoantibodies was transient in NOR mice and followed the same time-course as for NOD mice and they were all negative by 28 weeks (without progression to diabetes). No correlation was found in NOR mice between the levels of autoantibodies and insulitis. The program of insulin autoantibody expression is regulated over approximately 5 months for both NOD and NOR mice with only NOD mice developing diabetes, indicating that depending upon genetic combination, the presence of insulin autoantibodies does not always predict diabetes development. In addition, this data is not consistent with the hypothesis that the time-course of autoantibodies simply reflects the destruction of beta -cells with development of diabetes. (C) 2001 Academic Press.
引用
收藏
页码:1 / 6
页数:6
相关论文
共 17 条
[1]
Abiru N, 2000, DIABETES, V49, pA232
[2]
Abiru N, 2000, Diabetes Technol Ther, V2, P609, DOI 10.1089/15209150050502032
[3]
Checkpoints in the progression of autoimmune disease: Lessons from diabetes models [J].
Andre, I ;
Gonzalez, A ;
Wang, B ;
Katz, J ;
Benoist, C ;
Mathis, D .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (06) :2260-2263
[4]
CHARACTERIZATION OF INSULIN AUTOANTIBODIES IN RELATIVES OF PATIENTS WITH TYPE-I DIABETES [J].
CASTANO, L ;
ZIEGLER, AG ;
ZIEGLER, R ;
SHOELSON, S ;
EISENBARTH, GS .
DIABETES, 1993, 42 (08) :1202-1209
[5]
DANIEL D, 1995, EUR J IMMUNOL, V25, P1056, DOI 10.1002/eji.1830250430
[6]
EISENBARTH GS, 1986, NEW ENGL J MED, V314, P1360
[7]
Initiation of autoimmune diabetes by developmentally regulated presentation of islet cell antigens in the pancreatic lymph nodes [J].
Höglund, P ;
Mintern, J ;
Waltzinger, C ;
Heath, W ;
Benoist, C ;
Mathis, D .
JOURNAL OF EXPERIMENTAL MEDICINE, 1999, 189 (02) :331-339
[8]
INSULIN PROPHYLAXIS IN INDIVIDUALS AT HIGH-RISK OF TYPE-I DIABETES [J].
KELLER, RJ ;
EISENBARTH, GS ;
JACKSON, RA .
LANCET, 1993, 341 (8850) :927-928
[9]
NOR LT MICE - MHC-MATCHED DIABETES-RESISTANT CONTROL STRAIN FOR NOD MICE [J].
PROCHAZKA, M ;
SERREZE, DV ;
FRANKEL, WN ;
LEITER, EH .
DIABETES, 1992, 41 (01) :98-106
[10]
2 SUBSETS OF HLA-DQA1 ALLELES MARK PHENOTYPIC VARIATION IN LEVELS OF INSULIN AUTOANTIBODIES IN FIRST DEGREE RELATIVES AT RISK FOR INSULIN-DEPENDENT DIABETES [J].
PUGLIESE, A ;
BUGAWAN, T ;
MOROMISATO, R ;
AWDEH, ZL ;
ALPER, CA ;
JACKSON, RA ;
ERLICH, HA ;
EISENBARTH, GS .
JOURNAL OF CLINICAL INVESTIGATION, 1994, 93 (06) :2447-2452